VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ASCO GI 2021 | DPYD deficiency in patients with severe toxicity after 5-fluorouracil

Hans Prenen, MD, PhD, UZ Leuven, Leuven, Belgium, discusses the results of a retrospective single-center study evaluating the prevalence of dihydropyrimidine dehydrogenase (DPYD) deficiency in patients with severe toxicity after 5-fluorouracil in solid tumors. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter